{"id":"W3112543907","doi":"10.1093/ibd/izaa303","title":"Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry","year":2020,"lang":"en","type":"article","venue":"Inflammatory Bowel Diseases","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":57,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; Genentech; AbbVie; Leona M. and Harry B. Helmsley Charitable Trust; Pfizer; National Institute of Diabetes and Digestive and Kidney Diseases; Bristol-Myers Squibb Canada; Boehringer Ingelheim; Eli Lilly and Company","keywords":"Tofacitinib; Medicine; Coronavirus disease 2019 (COVID-19); Ulcerative colitis; Inflammatory bowel disease; Inflammatory Bowel Diseases; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Virology; Immunology; Internal medicine; Rheumatoid arthritis; Disease","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003548972,0.0001749921,0.0006052643,0.0006932694,0.0004004152,0.0006556835,0.0003275156,0.0003724478,0.002474097],"category_scores_gemma":[0.00109983,0.000141057,0.0005633942,0.001393385,0.0001893305,0.0006185327,0.0004838101,0.0007746363,0.0004243196],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004411406,"about_ca_system_score_gemma":0.0005010038,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002190119,"about_ca_topic_score_gemma":0.003134213,"domain_scores_codex":[0.9995697,0.00004245651,0.00008553612,0.00008958818,0.00009945471,0.0001131861],"domain_scores_gemma":[0.999307,0.00005775761,0.0002870035,0.00003741994,0.00009154994,0.0002192049],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0005581786,0.0001115473,0.9914243,0.00007849365,0.0001043428,0.0003639419,0.00009756738,0.0001182235,0.0001997932,0.00008644486,0.002058995,0.004798084],"study_design_scores_gemma":[0.00008095483,0.0004434495,0.9938709,0.00009518037,0.0001170836,0.001338895,0.0003929798,0.0002780094,0.00006889004,0.0001475983,0.003147694,0.00001833077],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9876103,0.002339476,0.0001669313,0.0003878193,0.00005494331,0.00006913118,0.00550174,0.00001355443,0.003855911],"genre_scores_gemma":[0.9887844,0.001179578,0.0001395889,0.0002544134,0.00008799924,0.00007790831,0.008931741,0.000009957333,0.0005343306],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002474097,"threshold_uncertainty_score":0.008276701,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01107671697525935,"score_gpt":0.2430421881232821,"score_spread":0.2319654711480227,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}